ArticleHeliyon2024

Evaluating the therapeutic effects of isotretinoin on patients with coronavirus disease 2019 (COVID-19): A controlled open-label clinical trial.

Maria Shirvani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.